Bo Anders Ljungqvist
Direttore operativo presso RhoVac ApS
Profilo
Bo Anders Ljungqvist was the founder of RhoVac AB, a company founded in 2015, where he held the title of Chief Operating Officer & Director from 2019 to 2022.
He is also currently working at RhoVac ApS since 2008, holding the title of Chief Operating Officer & Director since 2019.
In his former positions, he worked at The Leo Group as a Principal, at LEO Pharma A as Vice President-Regulatory Affairs from 1993 to 2003, at Invest AD Asset Management PJSC as Chief Investment Officer from 2000 to 2012, at Coegin Pharma.
AS as Head-Regulatory Affairs from 2005 to 2012, and at Ground Control Labs AS as a Business Manager.
Posizioni attive di Bo Anders Ljungqvist
| Società | Posizione | Inizio |
|---|---|---|
RhoVac ApS
 RhoVac ApS Pharmaceuticals: MajorHealth Technology Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019. | Direttore operativo | 02/09/2019 |
Precedenti posizioni note di Bo Anders Ljungqvist
| Società | Posizione | Fine |
|---|---|---|
| CHOSA ONCOLOGY AB | Amministratore Delegato | 02/09/2019 |
Invest AD Asset Management PJSC
 Invest AD Asset Management PJSC Financial ConglomeratesFinance Invest AD Asset Management PJSC (Invest AD) is the sovereign wealth manager of government-owned Abu Dhabi Investment Council. The firm was founded in 1977 and is headquartered in Abu Dhabi. Invest AD provides asset management services to international high-net worth individuals and institutions. | Direttore degli Investimenti | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Consigliere Generale | - |
Ground Control Labs AS
 Ground Control Labs AS Packaged SoftwareTechnology Services Ground Control Labs AS is a holding company that makes digital products. It develops the mobile and laptop social software Moot for various platforms. It provides social networking software for desktop computers and handheld devices. The company was founded by André Mlonyeni, Sigrid Bygdås, and Tore Urnes in 2006 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
The Leo Group
 The Leo Group Packaged SoftwareTechnology Services The Leo Group provides software solutions. The company develops custom applications using component technology to deliver solutions tailored to client needs. It provides applications using bar-code technology, multi-media and database integration, complex printer collation, and MS Office software automation. The company was founded in 1983 and is headquartered in Hershey, PA. | Technology Services |
Invest AD Asset Management PJSC
Invest AD Asset Management PJSC Financial ConglomeratesFinance Invest AD Asset Management PJSC (Invest AD) is the sovereign wealth manager of government-owned Abu Dhabi Investment Council. The firm was founded in 1977 and is headquartered in Abu Dhabi. Invest AD provides asset management services to international high-net worth individuals and institutions. | Finance |
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Health Technology |
Ground Control Labs AS
Ground Control Labs AS Packaged SoftwareTechnology Services Ground Control Labs AS is a holding company that makes digital products. It develops the mobile and laptop social software Moot for various platforms. It provides social networking software for desktop computers and handheld devices. The company was founded by André Mlonyeni, Sigrid Bygdås, and Tore Urnes in 2006 and is headquartered in Oslo, Norway. | Technology Services |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
RhoVac ApS
RhoVac ApS Pharmaceuticals: MajorHealth Technology Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Bo Anders Ljungqvist
